Biogen and Eisai Announce ADUHELM (aducanumab-avwa) Data Presentations at Alzheimer's Association International Conference 2021
Biogen and Eisai Announce ADUHELM (aducanumab-avwa) Data Presentations at Alzheimers Association International Conference 2021 - Item-level analysis from EMERGE trial shows consistency in slowing decline across cognitive, functional and behavioral measures in early Alzheimers disease - Presentations include an assessment of the correlation between reductions in amyloid beta and other biomarkers of Alzheimers disease and clinical decline after treatment with ADUHELM - Presentation on ARIA data ...
United States Lynn Kramer Alfred Sandrock Jr Japan Corporate News Network Head Of Research Alzheimer Association International Conference
Source: jcnnewswire.com